abstract |
A method for treating asthma in a patient using an agent selected from the group consisting of: n (a) an antibody capable of binding to ELAM-1; n (b) a fragment of the antibody (a), the fragment being capable of binding to ELAM-1; n (c) ELAM-1, being substantially free of natural contaminants; n (d) a functional derivative of ELAM-1; n (e) an antibody capable of binding to an ELAM-1 receptor; n (f) a fragment of the antibody (e), the fragment being capable of binding to an ELAM-1 receptor; n (g) an ELAM-1 receptor, being substantially free of natural contaminants; and . n (h) a functional derivative of an ELAM-1 receptor. |